Rapid and Highly Efficient CRISPR‐Cas9 RNP Genome Editing in Primary ILC2s. [[{“value”:”Arianna Maria Candelotti,
Giordana Garzillo,
Sara Bartolini,
Chiara Di Censo,
Giovanna Peruzzi,
Helena Stabile,
Cinzia Fionda,
Giuseppe Sciumè,
Giuseppe Pietropaolo”}]]
CRISPR-mediated gene editing enables efficient genetic manipulation of ILC2s through ex vivo or in vivo activation and Cas9 RNP delivery. This platform provides a robust approach to dissect gene function in ILC2s, with minimal manipulation.
